DIA 2022 Global Annual Meeting

Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Application UAN: 0286-0000-22-558-L04-P ; CME 1.00; RN 1.00

This session will explain how to apply principles of patient-focused drug development to cross-disciplinary functions within research and development and in regulatory strategy and reflect on best practices both in eliciting patient input and in translating it.

Learning Objectives

Identify and apply best practices in employing methods to capture patient experience data; Identify the importance of applying patient insights throughout the drug development and regulatory decision-making approaches through examples.

Chair

Kristina Bowyer

Speaker

Patient-Focused Drug Development Meetings and Beyond: Lessons Learned and Future Opportunities for Engaging FDA
James Valentine, JD, MHS

Obtaining Input From People With Kidney Diseases to Design and Evaluate New Drugs and Devices
Mark David Lim, PhD

Patient Perspective
Isabelle Lousada, MA